Betahistine dihydrochloride tor (racemic) CID16020046 antagonized agonist-induced receptor activation

CID16020046 antagonized agonist-induced receptor activation

is a novel derivative of cholic acid which acts as a potent and selective FXR agonist displaying anticholeretic activity in an in vivo rat model of cholestasis

DTXSID60385481

[3] Ultraviolet-A (UVA)-irradiated 1% Ampiroxicam sensitized in guinea pigs shows positive reaction in the patch testing to UVA-irradiated 1% Ampiroxicam and 1% thiosalicylate (TOS)

Betahistine dihydrochloride tor (racemic) CID16020046 antagonized agonist-induced receptor activationBetahistine is a histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers. Betahistine dihydrochloride is an anti vertigo drug. It is commonly prescribed for balance disorders or to alleviate vertigo symptoms associated with Mnire's disease. It was first registered in Europe in 1970 for the treatment of Mnire's disease. Product